Print
08 July 2014
MedCity News
Runa Capital, a Moscow-based global tech-focused venture capital firm, announced yesterday the first closing of its new fund, Runa Capital II. With a target size of $200 million, the firm will continue investing in tech-based companies worldwide, focusing especially on Europe. The amount of the first closing has not been disclosed.
Investors at this first closing come from across Europe, Russia and the USA, with large commitments from investors in the previous Runa Capital fund.
While the segment focus of Runa II will be similar to that of Runa I – including cloud computing, hosted services, virtualization, mobile applications and IT-solutions for education, healthcare, social and fintech – the geographical focus is shifting to invest more in Central, Eastern and Western European regions. Investments in Turkey, Israel and other areas of the world are not ruled out, though.
The fund has had three exits so far, starting in 2012 with the acquisition of its UK portfolio company Thinkgrid by ColtTelecom. In 2014, USA’s StopTheHacker was acquired by CloudFlare, and French startup Capptain was acquired by Microsoft.
Runa also had its failures, such as Travelmenu, a Russo-Ukrainian startup which shut down its service last year in spite of capital injections from Runa and other investors.
Among its other partfolio companies are NGINX, Jelastic, Ecwid, Zopa, Acumatica, Mambu, Wallarm, and drchrono.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.